Cargando…

Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment

Sputum cultures are an important tool in monitoring the response to tuberculosis treatment, especially in multidrug-resistant tuberculosis. There has, however, been little study of the effect of treatment regimen composition on culture conversion. Well-designed clinical trials of new anti-tuberculos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tierney, Dylan B., Franke, Molly F., Becerra, Mercedes C., Alcántara Virú, Félix A., Bonilla, César A., Sánchez, Epifanio, Guerra, Dalia, Muñoz, Maribel, Llaro, Karim, Palacios, Eda, Mestanza, Lorena, Hurtado, Rocío M., Furin, Jennifer J., Shin, Sonya, Mitnick, Carole D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169600/ https://www.ncbi.nlm.nih.gov/pubmed/25238411 http://dx.doi.org/10.1371/journal.pone.0108035

Ejemplares similares

Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality
por: Mitnick, Carole D., et al.
Publicado: (2013)

Long-term Follow-up for Multidrug-resistant Tuberculosis
por: Shin, Sonya S., et al.
Publicado: (2006)

Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
por: Tierney, Dylan B., et al.
Publicado: (2016)

The Reductionist Conundrum of an “Updated” Definition of Extensively Drug-Resistant Tuberculosis
por: Mitnick, Carole D., et al.
Publicado: (2021)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
por: Cox, Helen S, et al.
Publicado: (2015)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019)

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants
por: Odone, Anna, et al.
Publicado: (2016)

India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further
por: Udwadia, Zarir F, et al.
Publicado: (2021)

Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective
por: Rodriguez, Carly A., et al.
Publicado: (2023)

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial
por: Bouton, Tara C., et al.
Publicado: (2017)

Multiple Introductions of Multidrug-Resistant Tuberculosis into Households, Lima, Peru
por: Cohen, Ted, et al.
Publicado: (2011)

Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
por: Rodriguez, Carly A., et al.
Publicado: (2022)

El régimen Maderista
por: Bonilla, Manuel
Publicado: (1962)

Accuracy of digital chest x-ray analysis with artificial intelligence software as a triage and screening tool in hospitalized patients being evaluated for tuberculosis in Lima, Peru
por: Biewer, Amanda, et al.
Publicado: (2023)

Prevention and management of hearing loss in patients receiving ototoxic medications
por: Lindeborg, Michael M, et al.
Publicado: (2022)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru
por: Law, Stephanie, et al.
Publicado: (2023)

Das Regimen Sanitatis Konrads von Eichstätt
por: Dase, Sonya
Publicado: (1997)

Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now
por: Mitnick, Carole D, et al.
Publicado: (2007)

FAST tuberculosis transmission control strategy speeds the start of tuberculosis treatment at a general hospital in Lima, Peru
por: Tierney, Dylan B., et al.
Publicado: (2022)

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications
por: Rich, M. L., et al.
Publicado: (2023)

A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment
por: Lu, Chunling, et al.
Publicado: (2013)

Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis
por: Fox, Gregory J., et al.
Publicado: (2016)

Análisis y control del rendimiento deportivo /
por: Viru, A. A.
Publicado: (2003)

Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
por: Mitnick, Carole D., et al.
Publicado: (2023)

Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts
por: Brooks, Meredith B., et al.
Publicado: (2018)

Early mortality during rifampicin-resistant TB treatment
por: Mohr-Holland, E., et al.
Publicado: (2022)

Tolerance of skin care regimen in healthy, full-term neonates
por: Iarkowski, Laura Ellen, et al.
Publicado: (2013)

Analysis of the Performance of Neck Circumference to Identify Overweight and Obese Children
por: Virú-Loza, Manuel André
Publicado: (2021)

Régimen de incorporación fiscal /
por: Luna Guerra, Antonio
Publicado: (2014)

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis
por: Reuter, Anja, et al.
Publicado: (2023)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru
por: Tovar, Marco, et al.
Publicado: (2021)

Out-of-Hospital Surgical Airway Management: Does Scope of Practice Equal Actual Practice?
por: Furin, Molly, et al.
Publicado: (2016)

Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses
por: Brooks, Meredith B., et al.
Publicado: (2020)

Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management
por: de Almeida, Carlos Podalirio Borges, et al.
Publicado: (2023)

Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru
por: Yuen, Courtney M., et al.
Publicado: (2021)

Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient
por: El Nekidy, Wasim S., et al.
Publicado: (2017)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study
por: Becerra, Mercedes C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ojiu86c6i5f2av41anohh3n0h